MedPath

Diazepam

Diazepam Oral Solution, CIV 5 mg per 5 mL

Approved
Approval ID

b24f1eb7-3dab-4183-b81f-f86ac62aedd8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 15, 2021

Manufacturers
FDA

Pharmaceutical Associates, Inc.

DUNS: 044940096

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Diazepam

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0121-0905
Application NumberANDA070928
Product Classification
M
Marketing Category
C73584
G
Generic Name
Diazepam
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 15, 2021
FDA Product Classification

INGREDIENTS (9)

ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
SODIUM CITRATE, UNSPECIFIED FORMInactive
Code: 1Q73Q2JULR
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
DIAZEPAMActive
Quantity: 5 mg in 5 mL
Code: Q3JTX2Q7TU
Classification: ACTIB
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
POLYETHYLENE GLYCOL 1000Inactive
Code: U076Q6Q621
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Diazepam - FDA Drug Approval Details